GLOOKO
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2011-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.glooko.com
Insulin Degludec Titration Using Mobile Insulin Dosing System
Not Applicable
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Device: Glooko Mobile Insulin Dosing System(MIDS)
- First Posted Date
- 2017-03-27
- Last Posted Date
- 2020-03-05
- Lead Sponsor
- Glooko
- Target Recruit Count
- 240
- Registration Number
- NCT03091712
- Locations
- 🇺🇸
Scripps Whittier Diabetes Institute, San Diego, California, United States
Glooko mHealth Advantage Study
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Device: Glooko's mobile application
- First Posted Date
- 2016-11-28
- Last Posted Date
- 2021-06-03
- Lead Sponsor
- Glooko
- Target Recruit Count
- 197
- Registration Number
- NCT02974816
- Locations
- 🇺🇸
John Muir Physician Network Clinical Research Center, Concord, California, United States
🇺🇸Sutter Health, Elk Grove, California, United States
🇺🇸Scripps Whittier Diabetes Institute, San Diego, California, United States
© Copyright 2025. All Rights Reserved by MedPath